ISEC Healthcare (40T) Stock Overview
An investment holding company, provides medical care, consultancy, treatment, and surgery services in the field of ophthalmology in Singapore, Malaysia, and Myanmar. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
40T Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
ISEC Healthcare Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$0.32 |
| 52 Week High | S$0.38 |
| 52 Week Low | S$0.31 |
| Beta | -0.23 |
| 1 Month Change | -5.88% |
| 3 Month Change | -1.54% |
| 1 Year Change | -15.79% |
| 3 Year Change | 0% |
| 5 Year Change | 3.23% |
| Change since IPO | -13.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| 40T | SG Healthcare | SG Market | |
|---|---|---|---|
| 7D | -5.9% | 0.4% | 2.5% |
| 1Y | -15.8% | 24.6% | 28.1% |
Return vs Industry: 40T underperformed the SG Healthcare industry which returned 24.6% over the past year.
Return vs Market: 40T underperformed the SG Market which returned 28.1% over the past year.
Price Volatility
| 40T volatility | |
|---|---|
| 40T Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in SG Market | 13.4% |
| 10% least volatile stocks in SG Market | 2.6% |
Stable Share Price: 40T's share price has been volatile over the past 3 months compared to the SG market.
Volatility Over Time: Insufficient data to determine 40T's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | n/a | Jun Shyan Wong | www.isechealthcare.com |
ISEC Healthcare Ltd., an investment holding company, provides medical care, consultancy, treatment, and surgery services in the field of ophthalmology in Singapore, Malaysia, and Myanmar. It operates in two segments, Specialised Health Services and General Health Services. The company offers various services, including cataract and intraocular lens implant, refractive surgery, vitreous and retinal diseases, adult strabismus and paediatric ophthalmology, glaucoma diagnostics and therapeutics, medical retinal diseases, uveitis, optometry and orthoptics, oculoplastics, facial cosmetics, and aesthetic surgery, as well as cornea, external eye disease, and anterior segment.
ISEC Healthcare Ltd. Fundamentals Summary
| 40T fundamental statistics | |
|---|---|
| Market cap | S$184.22m |
| Earnings (TTM) | S$13.37m |
| Revenue (TTM) | S$79.21m |
Is 40T overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 40T income statement (TTM) | |
|---|---|
| Revenue | S$79.21m |
| Cost of Revenue | S$45.85m |
| Gross Profit | S$33.36m |
| Other Expenses | S$19.99m |
| Earnings | S$13.37m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.023 |
| Gross Margin | 42.12% |
| Net Profit Margin | 16.88% |
| Debt/Equity Ratio | 16.2% |
How did 40T perform over the long term?
See historical performance and comparisonDividends
Does 40T pay a reliable dividends?
See 40T dividend history and benchmarks| ISEC Healthcare dividend dates | |
|---|---|
| Ex Dividend Date | May 11 2026 |
| Dividend Pay Date | May 26 2026 |
| Days until Ex dividend | 52 days |
| Days until Dividend pay date | 67 days |
Does 40T pay a reliable dividends?
See 40T dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/19 01:24 |
| End of Day Share Price | 2026/03/18 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ISEC Healthcare Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gregory Yap | Maybank Research Pte. Ltd. |